David H. Abramson

Last updated

David H. Abramson (born February 1944), is a clinician scientist, ophthalmic surgeon, competitive swimmer, and lecturer who has published over 700 peer-reviewed articles in ophthalmology, with a focus on ophthalmic oncology. [1] Abramson was the first chief of the ophthalmic oncology service at Memorial Sloan Kettering Cancer Center, where he is a tenured professor in surgery, pediatrics, and radiation oncology. [1] He is also a professor at Weill Cornell Medicine, where he was the youngest full professor ever appointed in ophthalmology. [2] He pioneered intra-arterial chemotherapy, which cures cancer whilst saving the eye from enucleation, in 2006. He is the recipient of many awards, including the Stallard Medal [3] from the International Society for Oncular Oncology, the Lifetime Achievement Award from the American Academy of Ophthalmology, the Weisenfeld Award [4] from the Association for Research In Vision and Ophthalmology, and the Franceshcetti Medal from the International Society of Genetic Eye Disease in Switzerland. [5] [1] In addition to his academic pursuits, Abramson was a triple gold medal winner in swimming at the Maccabiah Games in Israel in 1961, [6] set four NCAA records during his time as the Captain of the Harvard University swim team, [7] and was an Olympic alternate in 1960 for the 800 meter relay team. He has been inducted into three halls of fame: the Retina Hall of Fame, [8] the Harvard Varsity Club Hall of Fame, [9] and the Brooklyn Technical High School Hall of Fame. [10]

Contents

Early life

Abramson was born in New York, New York. His father, Jack Abramson, was President of a garment company, the Diamond Tea Gown Company, [11] and served on the board of the U.S. Olympic Committee; [12] his mother, Ruth Abramson, was the executive designer for the company and was inducted into the New York University Athletics Hall of Fame for four sports — basketball, field hockey, tennis, and swimming. [13]

Education

In 1961, Abramson graduated from Brooklyn Technical High School where he received the All-Tech Medal. [10]

From there, he went on to Harvard University, where he graduated with an A.B. in Biology in 1965. While he was there, he served as Captain of the Freshman and the Varsity Men's Swimming Teams, where he was a four-time All-American and went undefeated in collegiate competition. [14] He was also a member of the Fly Club and the Hasty Pudding Club while an undergraduate. Upon graduation, he was elected First Marshal of the Class of 1965, [15] a position in which he still serves.

Abramson subsequently enrolled in medical school at the Albert Einstein College of Medicine, and received his M.D. in 1969. [1] He did additional training during residency at the Armed Forces Institute of Pathology in Washington, D.C. [1]

After residency, he received a Heed [16] Fellowship to study Ophthalmic Oncology at Columbia University.

Career

In 1969, Abramson began his internship in medicine at Lincoln Hospital/Albert Einstein Medical Center. The following year, in 1970, he began a residency in Ophthalmology at the Edward S. Harkness Eye Institute at Columbia Presbyterian Medical Center, where he studied under Dr. Robert Ellsworth. [17]

Upon completion of his residency, he completed a Fellowship in Ophthalmic Oncology at Columbia Presbyterian Medical Center. [1]

Post fellowship, in 1974, Abramson joined the staff at Columbia Presbyterian as an attending physician in Ophthalmology. [1]

In 1979, he moved to New York Hospital/Cornell University Medical Center, where he was appointed clinical professor in Ophthalmology. He was also in private surgical practice at this time.

In 2004, he moved to Memorial Sloan Kettering Cancer Center to start the Ophthalmic Oncology service, and has served as Chief of Ophthalmic Oncology since. [18] He continues to serve as a professor at Cornell University, now Weill-Cornell Medical College.

Related Research Articles

<span class="mw-page-title-main">Memorial Sloan Kettering Cancer Center</span> Treatment and research hospital in New York City

Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in Manhattan in New York City. MSKCC is one of 72 National Cancer Institute-designated Comprehensive Cancer Centers. Its main campus is located at 1275 York Avenue between 67th and 68th Streets in Manhattan.

<span class="mw-page-title-main">Weill Cornell Medicine</span> Medical school of Cornell University

Weill Cornell Medicine, formally the Joan & Sanford I. Weill Medical College of Cornell University, is the biomedical research and medical school of Cornell University. It is located on the Upper East Side of New York City.

<span class="mw-page-title-main">Tri-Institutional MD–PhD Program</span> Academic program in New York City

The Tri-Institutional MD–PhD Program is an academic program of study based in New York City that was formed by combining earlier MD–PhD programs that had their inceptions in 1972. The current version of the program, which is operated by Weill Cornell Medicine, Rockefeller University, and Memorial Sloan Kettering Cancer Center's Sloan Kettering Institute, was created in 1991.

<span class="mw-page-title-main">José Baselga</span> Spanish oncologist (1959–2021)

Josep Baselga i Torres, known in Spanish as José Baselga, was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein, which is impacted in aggressive breast cancers.

The Tri-Institutional Training Program in Computational Biology and Medicine or Tri-I CBM is a PhD program that exists as a partnership between the Weill Cornell Medical College (WMC), Rockefeller University, and Memorial Sloan-Kettering Cancer Center (MSKCC). The program is in part designed to encourage collaboration and a sense of connectedness between the two branches of Cornell University and the other institutions in Manhattan. Dr. Christina Leslie is the current director of the program.

William S. Breitbart, FAPM, is an American psychiatrist in Psychosomatic Medicine, Psycho-oncology, and Palliative Care. He is the Jimmie C Holland Chair in Psychiatric Oncology, and the Chief of the Psychiatry Service, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, He is a Professor of Clinical Psychiatry at Weill Medical College of Cornell University. He was president of the Academy of Psychosomatic Medicine, and the Editor-in-Chief of Palliative and Supportive Care.

Paul T. Finger, MD, FACS, is an ophthalmologist in New York, New York, specializing in ocular oncology. Finger is a Clinical Professor of Ophthalmology at the New York University School of Medicine in New York City, New York. He is also the director of The New York Eye Cancer Center and Ocular Tumor Services at The New York Eye and Ear Infirmary of Mt. Sinai. He consults for Northwell Health Complex of affiliated Hospitals including Manhattan Eye, Ear and Throat Hospital and NYU School of Medicine. He is Chair of the Ophthalmic Oncology Task Force for the American Joint Committee on Cancer (AJCC), wrote the eye cancer staging systems section for the Union International for Cancer Control (UICC). As Chair, he brought together an OOTF to develop consensus eye plaque radiation guidelines for The American Brachytherapy Society - American Association of Physicists in Medicine. Dr. Finger was the first the only ophthalmologist asked to serve on the 2012 American Association of Physicists in Medicine’s Task Group-129 that produced both dosimetry and quality assurance standards for plaque brachytherapy. As of 2021, Dr. Finger has authored over 335 peer-review scientific articles, 2 books, 54 book chapters and 2 web sites.

Robert E. Wittes was Physician-in-Chief of Memorial Sloan-Kettering Cancer Center, from 2002 until December 31, 2012. Prior to his appointment at MSKCC, he was Deputy Director for Extramural Sciences and Director of the Division of Cancer Treatment and Diagnosis at the National Cancer Institute, where he oversaw NCI's extramural clinical and basic research programs, including the evaluation of new therapeutics, diagnostics, and translational research. Wittes is a fellow of the American College of Physicians, a member of the American Association for Cancer Research, the American Society of Clinical Oncology, and the American Federation for Medical Research. In addition to his institutional affiliations, Dr. Wittes has served as editor-in-chief of the Journal of the National Cancer Institute and Oncology. He has served on the editorial boards of Clinical Cancer Research, Current Opinion in Oncology, The American Journal of Clinical Oncology; Cancer Investigation, and The International Journal of Radiation Oncology-Biology & Physics, among others.

Simon N. Powell is a British cancer researcher and radiation oncologist residing in New York City.

George Bosl is an American cancer researcher, holder of the Patrick M. Byrne Chair in Clinical Oncology at the Memorial Sloan-Kettering Cancer Center in New York City, and is a professor of medicine at the Weill Cornell Medical College. In 1997, he was appointed chair of the Department of Medicine at Sloan-Kettering, a position which he held until 2015. In 2019, he was named Memorial Sloan Kettering's first ombudsperson.

Peter T. Scardino is an American cancer surgeon, researcher, and author expert in genitourinary and urological cancers particularly cancer of the prostate. He is chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center.

<span class="mw-page-title-main">Kenneth Offit</span> American geneticist

Kenneth Offit is an American cancer geneticist and oncologist known for his discoveries with respect to the genetic bases of breast, colorectal, and lymphoid cancers. He is currently Chief of the Clinical Genetics Service and the Robert and Kate Niehaus Chair in Inherited Cancer Genomics at Memorial Sloan Kettering Cancer Center. Offit is also a member of the Program in Cancer Biology and Genetics at the Sloan-Kettering Institute and Professor of Medicine and Healthcare Policy and Research at Weill Cornell Medical College. He was previously a member of both the Board of Scientific Counselors of the National Cancer Institute and the Evaluation of Genomic Applications in Practice and Prevention working group of the U.S. Centers for Disease Control.

Jeffrey Philip Gold is an American surgeon, medical educator, and academic administrator who has been the president of the University of Nebraska system since July 1, 2024. Prior to that, he served as the chancellor of the University of Nebraska Medical Center since February 1, 2014, as well as the executive vice president and provost of the University of Nebraska system since 2021. He also previously served as the interim chancellor and then chancellor of the University of Nebraska Omaha from May 2017 to June 2021.

Howard I. Scher is the Chief of the Genitourinary Oncology at Memorial Sloan Kettering Cancer Center and Professor of Medicine at the Weill Cornell Medical College. He has a depth of experience in clinical trials for novel types of cancer treatment.

Robert Maki is an American medical oncologist, Professor of Medicine at the Hospital of the University of Pennsylvania, He is a specialist in the management of and translational research regarding sarcoma, the group of connective tissue malignancies that include leiomyosarcoma, gastrointestinal stromal tumor (GIST), liposarcoma, angiosarcoma, Ewing sarcoma, desmoid tumor and many others.

Kornelia Polyak is a professor of medicine at Harvard Medical School and an internationally recognized breast cancer expert.

Dr. Kathleen M. Foley is an American physician. She was an Attending Neurologist at Memorial Sloan-Kettering Cancer Center in New York City. She worked as a professor of Neurology, Neuroscience, and Clinical Pharmacology at Cornell University Weill Medical College. Foley made contributions toward making palliative care for cancer patients accessible. She headed the country's first pain service in a cancer center at Memorial Sloan-Kettering and was the medical director of the Supportive Care Program. In 1999, she became the director of the Open Society Institute's Project on Death in America. Additionally, Foley was the Director of the WHO Collaborating Center for Cancer Pain Research and Education at Memorial Sloan-Kettering Cancer Center. She holds the Chair of the Society of Memorial Sloan-Kettering Cancer Center in Pain Research and continues to work with the Open Society Institute as the Medical Director of the International Palliative Care Initiative of the Network Public Health Program of the Research.

<span class="mw-page-title-main">Philip Kantoff</span> Medical researcher

Philip W. Kantoff is a medical oncologist. He is the chairman and chief executive officer (CEO) of Convergent Therapeutics. He served as the Chairman of Medicine at Memorial Sloan Kettering Cancer Center between 2015 and 2021. He is best known for his contributions to the impact of DNA abnormalities in prostate cancer and the discovery of therapies for metastatic hormone-sensitive prostate cancer.

<span class="mw-page-title-main">Rosandra N. Kaplan</span> American pediatric oncologist and scientist

Rosandra N. Kaplan is an American pediatric oncologist and scientist specialized in translational and clinical research on the mechanisms of cancer spread and the role of the tumor microenvironment in cancer progression. She is a principal investigator and head of the tumor microenvironment and metastasis branch at the National Cancer Institute.

Carol L. Brown is the Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering Cancer Center and a professor at Weill Cornell Medical College. She is a surgeon known for her work on gynecological cancers.

References

  1. 1 2 3 4 5 6 7 "David H. Abramson, MD — MSK Ophthalmic Oncologist". www.mskcc.org. Retrieved July 17, 2024.
  2. ↑ "Abramson, David Harold". vivo.weill.cornell.edu. Retrieved July 17, 2024.
  3. ↑ "View Awards". ISOO. Retrieved July 17, 2024.
  4. ↑ Haik, Barrett G. (August 1, 2005). "Introducing David H. Abramson, the 2004 Recipient of the Weisenfeld Award". Investigative Ophthalmology & Visual Science. 46 (8): 2683. doi:10.1167/iovs.04-1067. ISSN   1552-5783.
  5. ↑ "ISGEDR website". ISGEDR website.
  6. ↑ "U.S. Gains Four Gold Medals In Maccabiah Games Swimming; Abramson, Zakim and Misses Miller and Chesneau Score -- Herman Sets Mark in Retaining Decathlon Crown". The New York Times. September 2, 1961. ISSN   0362-4331 . Retrieved July 17, 2024.
  7. ↑ "Abramson to Captain Swimming Team". The Harvard Crimson . March 25, 1964. Retrieved July 17, 2024.
  8. ↑ "David H. Abramson, MD, FACS — Retina Reflections". retinahistory.asrs.org. Retrieved July 17, 2024.
  9. ↑ "David Abramson – Harvard Varsity Club". harvardvarsityclub.org. Retrieved July 17, 2024.
  10. 1 2 "David H. Abramson, MD '61 | Brooklyn Tech Alumni Foundation". January 27, 2023. Retrieved July 17, 2024.
  11. ↑ Saxon, Wolfgang (August 14, 1993). "Jack Abramson, 79, A Garment Maker And Sports Official". The New York Times. ISSN   0362-4331 . Retrieved July 17, 2024.
  12. ↑ "Jack Abramson '32 | Brooklyn Tech Alumni Foundation". January 27, 2023. Retrieved July 17, 2024.
  13. ↑ "Ruth Diamond (Abramson) (1978) - Hall of Fame". NYU Athletics. Retrieved July 17, 2024.
  14. ↑ "Abramson Sets New National Mark As Swimmers Top Dartmouth, 60-35 | News | The Harvard Crimson". www.thecrimson.com. Retrieved July 17, 2024.
  15. ↑ "Abramson Selected First Class Marshal". The Harvard Crimson . January 21, 1965. Retrieved July 17, 2024.
  16. ↑ "Home". HEED Site.
  17. ↑ Saxon, Wolfgang (January 5, 1994). "R. M. Ellsworth, 65, A Medical Specialist In Cancer of the Eye". The New York Times. ISSN   0362-4331 . Retrieved July 17, 2024.
  18. ↑ "Ophthalmic Oncology Fellowship | Memorial Sloan Kettering Cancer Center". www.mskcc.org. Retrieved July 17, 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.